Jama : Journal of the American Medical Association, 317, 23, pp. 2402-2416 JAMA, 317(23), 2402-2416. American Medical Association Jama : Journal of the American Medical Association, 317, 2402-2416 Kuchenbaecker, K B, Hopper, J L, Barnes, D R, Phillips, K-A, Mooij, T M, Roos-Blom, M-J, Jervis, S, McGuffog, L, Evans, D, Barrowdale, D, Frost, D, Adlard, J, Ong, K, Izatt, L, Tischkowitz, M, Eeles, R, Davidson, R, Hodgson, S, Ellis, S, Nogues, C, Lasset, C, Stoppa-Lyonnet, D, Fricker, J-P, Faivre, L, Berthet, P, Hooning, M J, van der Kolk, L, Kets, C M, Adank, M A, John, E M, Chung, W K, Andrulis, I L, Southey, M, Daly, M B, Buys, S S, Osorio, A, Engel, C, Kast, K, Schmutzler, R K, Caldes, T, Jakubowska, A, Simard, J, Friedlander, M L, McLachlan, S A, Machackova, E, Foretova, L, Tan, Y Y, Singer, C F, Olah, E, Gerdes, A-M, Arver, B, Olsson, H, van Leeuwen, F E, Milne, R L, Andrieu, N, Goldgar, D E, Terry, M B, Rookus, M A, Easton, D F & Antoniou, A C 2017, ' Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers ', JAMA: The Journal of the American Medical Association . https://doi.org/10.1001/jama.2017.7112